Eyegate Pharmaceuticals Inc Warrants 2015-2020 On Shs

( )
EYEGW PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SHPGShire PLC Sponsored ADR
AMRNAmarin Corporation Plc Sponsored ADR
JAZZJazz Pharmaceuticals Plc
PRGOPerrigo Co. Plc
GWPHGW Pharmaceuticals PLC Sponsored ADR
MNKMallinckrodt Plc
UTHRUnited Therapeutics Corporation
ICPTIntercept Pharmaceuticals, Inc.
SAGESAGE Therapeutics, Inc.
HZNPHorizon Pharma plc
CTLTCatalent Inc
ENDPEndo International Plc
ZGNXZogenix, Inc.
MDCOMedicines Company

Company Profile

EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.S. FDA. The company was founded in 1998 and is headquartered in Waltham, MA.